Ocular Therapeutix (OCUL): Aggressively advancing the clinical pipeline, anticipating significant clinical results by Q2 2024. Inter & Co. Inc. (INTR): Attained remarkable customer growth, surpassing ...
Source LinkOcular Therapeutix (OCUL): Aggressively advancing the clinical pipeline, anticipating significant clinical results by Q2 2024. Inter & Co. Inc. (INTR): Attained remarkable customer growth, surpassing ...
Source Link
Comments